Browse by Audience
MEMBER

Update Your Profile
Special Interest Groups (SIG)
Member Spotlights
IASP Connect
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Pain Researcher
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Curricula
Graduate Opportunities
Treatment and Education Resources
Events

PATIENT & CAREGIVER

Resources for Living with Pain
Topic Pages
Free Videos
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner
Make a Donation

I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / A Comprehensive Update of Lofexidine for the Management of Opioid Withdrawal Symptoms.

< BACK TO ARCHIVE


2020 Jul 23


Psychopharmacol Bull


http://www.ncbi.nlm.nih.gov/pubmed/32733113?dopt=Abstract


50


3

A Comprehensive Update of Lofexidine for the Management of Opioid Withdrawal Symptoms.

Authors

A Comprehensive Update of Lofexidine for the Management of Opioid Withdrawal Symptoms.
Urits I, Patel A, Zusman R, Virgen C G, Mousa M, Berger AA, Kassem H, Jung J W, Hasoon J, Kaye AD, Viswanath O
Psychopharmacol Bull. 2020 Jul 23; 50(3):76-96.
PMID: 32733113.

Abstract

This is a comprehensive review of the literature regarding the use of Lofexidine for opiate withdrawal symptoms. It covers the background and necessity of withdrawal programs and the management of withdrawal symptoms and then covers the existing evidence of the use of Lofexidine for this purpose.